Global Market For Anticoagulant Drugs To Reach Nearly $5.4 Billion In 2017
11/21/2012

According to a new technical market research report, ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM119A)

Online PR News – 21-November-2012 – Wellesley, MA – Wellesley, Mass. – According to a new technical market research report, ANTITHROMBOTIC/ANTICOAGULANT DRUGS: TECHNOLOGIES AND GLOBAL MARKETS (PHM119A), from BCC Research (www.bccresearch.com), the global anticoagulant drug market was valued at nearly $5.8 billion in 2011 and should reach nearly $5.7 billion in 2012. Total market value is expected to reach nearly $5.4 billion in 2017 after decreasing at a five-year compound annual growth rate (CAGR) of -1.1%.
The market for anticoagulant drugs can be broken down into four regions: the United States, Europe, Japan, and the rest of the world.
The market in the United States is expected to have a value of $2.8 billion in 2012 and $2.2 billion in 2017, a CAGR of -4.5%.
As a segment, Europe should total $1.6 billion in 2012 and $1.6 billion in 2017, a CAGR of -0.3%.
Japan is expected to total $504 million in 2012 and reach nearly $509 million in 2017, a CAGR of 0.2%.
The rest of the world is expected to have a value of nearly $703 million in 2012 and reach nearly $996 million in 2017, a CAGR of 7.2%.
The primary functions of the circulatory system are to transport oxygen and nutrients to the body and remove waste products. In order to accomplish these functions, a complex circuitry of vessels travels throughout the body powered by the pumping action of the heart. Movement of blood through the lungs is provided by the right side of the heart. Systemic blood flow is supplied by the left side of the heart.
Nutrients are absorbed into the blood as it moves through the gastrointestinal tract by the splanchnic circulation. Oxygen uptake and the release of carbon dioxide occur in the specialized vascular bed of the pulmonary circulation. The liver, with its extensive blood supply, has a major role in metabolism and the generation of metabolic waste products. These and other metabolic byproducts are carried by the blood to the kidneys for elimination. Inadequate circulation in the lungs, liver or kidneys may interfere with the removal of metabolic waste from the body. Effective transportation of oxygen and nutrients and the removal of waste materials depend on proper functioning of the circulatory system.

This report will help its readers:

• Forecast the market size for anticoagulant drugs in terms of dollar and unit sales
• Classify the market size for anticoagulant drugs by geographical regions in terms of dollar and unit sales
• Highlight the roles played by major stakeholders and players
• Provide an overview of the activities of influential companies
• Examine crucial, innovative breakthroughs by means of a detailed patent analysis.

This report will be valuable to many industry participants, including the following:

• Antithrombotic and anticoagulant drug specialists
• Anticoagulant drug manufacturers
• End users and distributors
• Academic and research distributors
• Financial institutions.